Active	Status	Sponsor type	Region	Phase	Filter
3 Active 3 Inactive 6 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Moreno, Francisco
MM09-SIT-023, NCT04435990 / 2018-004262-34: Efficacy and Safety Evaluation for the Treatment of Allergy Against Mites	Recruiting	3	150	Europe	10,000 MM09, 30,000 MM09, Placebo subcutaneous	Inmunotek S.L., BioClever 2005 S.L.	Rhinitis, Allergic, Rhinoconjunctivitis, Asthma, Allergic	01/24	12/25
NCT05624268: Efficacy, Safety, and Tolerability of COMP360 in Participants With TRD	Recruiting	3	255	US	Psilocybin, COMP360	COMPASS Pathways	Treatment Resistant Depression	02/25	02/26
PSILOCD, NCT03300947: Psilocybin for Treatment of Obsessive Compulsive Disorder	Completed	1	15	US	Psilocybin 100 mcg/kg, Psilocybine, "magic mushrooms", Psilocybin 300 mcg/kg, Lorazepam 1 mg, Ativan, Intensol	University of Arizona	Obsessive-compulsive Disorder (OCD)	10/23	12/23